Location: Munich
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Munich
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Observational Study Protocol: LIVER-R Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Phase 3 · Klinikum Rechts Der Isar Der Technischen Universität München · Eli Lilly and Company · NCT07218380 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 Evaluation of the Naturalistic User Experience of the Website "ich Bin Alles @Schule" (i Am Everything @school) Phase N/A · LMU University Hospital (recruitment is conducted online) · Ludwig-Maximilians - University of Munich · NCT06668688 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Phase 2/Phase 3 · TUM Klinikum · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) Phase 3 · Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Frauen · Merck Sharp & Dohme LLC · NCT06393374 Freder1k-Study - Testing Infants for Type 1 Diabetes Risk Phase N/A · Institut für Diabetesforschung, Helmholtz Zentrum München · Helmholtz Zentrum München · NCT03316261 Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD NA · University Munich · Ad scientiam · NCT05566769 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy Phase N/A · Klinik und Poliklinik für Strahlentherapie und Radioonkologi · University of Erlangen-Nürnberg Medical School · NCT07131956 Register of Blood Stem Cell Transplantation Phase N/A · Klinikum rechts der Isar der TU München · Technical University of Munich · NCT04263857 Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III) NA · European Radiosurgery Center Munich · University Hospital Schleswig-Holstein · NCT06914544 Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic Phase N/A · Department of Urology, LMU University Hospital, Ludwig-Maxim · Comprehensive Cancer Center Munich (CCCM) · NCT06657157 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie Phase 3 · Pfizer · NCT05895786 The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma Phase N/A · Technical University Munich · Erasmus Medical Center · NCT06273176 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease Phase 3 · TUM Klinikum · Bristol-Myers Squibb · NCT06976216 Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial) NA · University of Leipzig · NCT03469609 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes Phase 2 · SAb Biotherapeutics, Inc. · NCT07187531 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) Phase 2 · Klinikum der Universität München Großhadern ( Site 0910) · Merck Sharp & Dohme LLC · NCT06833073 Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic D Phase 2 · Site number - 6502 · Immunovant Sciences GmbH · NCT06979531 A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING Phase N/A · Praxiszentrum Dr. Med. Klaus Kruger Dres. Günther Kellerer U · AbbVie · NCT06712628 Infectious Complications After Cystectomy: A Prospective Observational Study Phase N/A · Urology Department - LMU Klinikum · Ludwig-Maximilians - University of Munich · NCT05153694 Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1 Phase 3 · LMU Klinikum der Universität München Neurologische Klinik un · Dyne Therapeutics · NCT07486934 HOPE Against Cancer Recurrence in HCC Phase 4 · Philipp Dutkowski · NCT06717919 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719 Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy NA · Okuvision GmbH · NCT07531927 TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium NA · Department of Cardiovascular Surgery, German Heart Center Mu · Deutsches Herzzentrum Muenchen · NCT03600662 Pan Tumor Rollover Study Phase 2 · Local Institution - 0276 · Bristol-Myers Squibb · NCT03899155 A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas). Phase 3 · University Hospital rechts der Isar, Radiation Oncology · University Hospital Heidelberg · NCT05331521 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R- Phase 2 · LMU Klinikum ( Site 0428) · Merck Sharp & Dohme LLC · NCT06890884
Look up another city
Look up another condition